-
Dr. WeiCao: Focus on Managing HIV Complications, Further Improving Patient Survival
-
Interview with Dr. Melissa L. Johnson at WCLC 2023
-
Dr.HongzhouLu: NAD Management is Key for HIV Patients, Not Just Changing Medication
-
SGBCC International Dialogue | Dr. JianZhang Discusses with Dr. Harbeck: Is Chemotherapy Necessary for ER+/HER2- Breast Cancer Patients with Low Genetic Risk but High Clinical Risk?
-
SGBCC 2023 | Academician BingheXu: Breast Cancer Treatment and Research – An Asian Perspective
-
SGBCC International Dialogue|Dr. LiZhu & Dr. Giuseppe Curigliano Discuss the Need for Adjuvant Therapy After Achieving pCR in Neoadjuvant Treatment
-
WCLC 2023 | Dr. Ramalingam Shares Wining Statement as a Winner of the IASLC Scientific Award
-
Interview with Dr. Andreas Rimner: The Role of Radiotherapy in the Treatment of Stage III Thymoma
-
Interview with Dr. Martin Reck at ELCC 2023
-
Dr. P. Garrido Lopez Interprets Latest Data from CHRYSALIS
-
Interview with Dr. Luis Paz-Ares: PD-L1 High Expression in Advanced NSCLC, IO Monotherapy vs. IO + Chemotherapy
-
Dr. Ryan Jacobs: Bispecific Antibodies Bring New Progress in Follicular Lymphoma Treatment, New CD79b ADC Drugs Show Significant Value in DLBCL Treatment!
Connecting Medical Expertise through Media